Profil
Dr. Dimitris Voliotis, MD, is a Chief Medical Officer at Radiopharm Theranostics Ltd. Dr. Voliotis was previously employed as a Senior Vice President-Clinical Development by Zentalis Pharmaceuticals, Inc., a Chief Development Officer by CureVac AG, a Global Head-Clinical Development Oncology by Eisai, Inc., and a Vice President & Head-Oncology Group by Bayer HealthCare AG.
He received his doctorate degree from Universität zu Köln.
Aktive Positionen von Dimitris Voliotis
| Unternehmen | Position | Beginn |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 20.08.2024 |
Ehemalige bekannte Positionen von Dimitris Voliotis
| Unternehmen | Position | Ende |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.09.2023 |
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Corporate Officer/Principal | 01.02.2020 |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Corporate Officer/Principal | 01.01.2019 |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Corporate Officer/Principal | 01.09.2014 |
Ausbildung von Dimitris Voliotis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Radiopharm Theranostics Ltd.
Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
















